Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
21.33
+0.29 (1.38%)
At close: Mar 9, 2026, 4:00 PM EDT
21.40
+0.07 (0.33%)
After-hours: Mar 9, 2026, 5:19 PM EDT
Immunome Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 653.48 | 143.35 | 98.68 | 20.32 | 49.23 | Upgrade
|
| Short-Term Investments | - | 73.95 | 39.46 | - | - | Upgrade
|
| Cash & Short-Term Investments | 653.48 | 217.3 | 138.14 | 20.32 | 49.23 | Upgrade
|
| Cash Growth | 200.72% | 57.30% | 579.73% | -58.72% | 23.80% | Upgrade
|
| Accounts Receivable | - | - | - | - | 1.64 | Upgrade
|
| Other Receivables | - | - | - | 0.85 | 2.67 | Upgrade
|
| Receivables | - | - | - | 0.85 | 4.31 | Upgrade
|
| Prepaid Expenses | 7.3 | 4.04 | 6.56 | 1.03 | 2.51 | Upgrade
|
| Other Current Assets | - | - | - | 0.45 | 0.59 | Upgrade
|
| Total Current Assets | 660.78 | 221.34 | 144.7 | 22.65 | 56.64 | Upgrade
|
| Property, Plant & Equipment | 17.61 | 14.39 | 3.64 | 0.97 | 0.86 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 0.33 | 0.33 | Upgrade
|
| Other Long-Term Assets | 4.8 | 4.51 | 0.2 | 0.1 | 0.1 | Upgrade
|
| Total Assets | 683.19 | 240.24 | 148.54 | 24.05 | 57.93 | Upgrade
|
| Accounts Payable | 3.34 | 14.19 | 3.31 | 2.4 | 3.08 | Upgrade
|
| Accrued Expenses | 38.03 | 25.14 | 6.98 | 4.62 | 4.31 | Upgrade
|
| Current Portion of Leases | - | 0.06 | 0.31 | 0.23 | - | Upgrade
|
| Current Unearned Revenue | - | 6.94 | 10.49 | - | - | Upgrade
|
| Other Current Liabilities | 3.63 | 7.98 | 0.73 | 0.09 | 2.34 | Upgrade
|
| Total Current Liabilities | 44.99 | 54.31 | 21.83 | 7.33 | 9.73 | Upgrade
|
| Long-Term Leases | 3.86 | 4.77 | 1.34 | 0.06 | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | 5.49 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.01 | Upgrade
|
| Total Liabilities | 48.85 | 59.08 | 28.66 | 7.39 | 9.74 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,362 | 696.87 | 342.66 | 132.65 | 127.29 | Upgrade
|
| Retained Earnings | -728.16 | -515.77 | -222.81 | -116 | -79.11 | Upgrade
|
| Comprehensive Income & Other | - | 0.06 | 0.02 | - | - | Upgrade
|
| Total Common Equity | 634.34 | 181.17 | 119.88 | 16.65 | 48.19 | Upgrade
|
| Shareholders' Equity | 634.34 | 181.17 | 119.88 | 16.65 | 48.19 | Upgrade
|
| Total Liabilities & Equity | 683.19 | 240.24 | 148.54 | 24.05 | 57.93 | Upgrade
|
| Total Debt | 3.86 | 4.83 | 1.65 | 0.29 | - | Upgrade
|
| Net Cash (Debt) | 649.63 | 212.47 | 136.49 | 20.03 | 49.23 | Upgrade
|
| Net Cash Growth | 205.75% | 55.67% | 581.37% | -59.31% | 25.74% | Upgrade
|
| Net Cash Per Share | 7.44 | 3.62 | 6.88 | 1.65 | 4.27 | Upgrade
|
| Filing Date Shares Outstanding | 113.13 | 86.95 | 59.69 | 12.22 | 12.13 | Upgrade
|
| Total Common Shares Outstanding | 113.13 | 64.46 | 43.25 | 12.13 | 12.11 | Upgrade
|
| Working Capital | 615.79 | 167.03 | 122.87 | 15.32 | 46.91 | Upgrade
|
| Book Value Per Share | 5.61 | 2.81 | 2.77 | 1.37 | 3.98 | Upgrade
|
| Tangible Book Value | 634.34 | 181.17 | 119.88 | 16.65 | 48.19 | Upgrade
|
| Tangible Book Value Per Share | 5.61 | 2.81 | 2.77 | 1.37 | 3.98 | Upgrade
|
| Machinery | 11.29 | 9.93 | 5.75 | 3.94 | 3.69 | Upgrade
|
| Construction In Progress | 5.55 | 3.3 | - | - | - | Upgrade
|
| Leasehold Improvements | 4.16 | 1.64 | 0.23 | 0.19 | 0.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.